Evidence map›Paper›PMID 34075638›Full record

ArticleProtein science : a publication of the Protein Society2021

Biochemical properties of VGLL4 from Homo sapiens and Tgi from Drosophila melanogaster and possible biological implications.

Yannick Mesrouze, Marco Meyerhofer, Catherine Zimmermann, Patrizia Fontana, Dirk Erdmann, Patrick Chène

Open access · bronzeAbstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Yannick MesrouzeDisease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Marco MeyerhoferDisease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Catherine ZimmermannDisease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Patrizia FontanaDisease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Dirk ErdmannDisease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.
Patrick ChèneDisease Area Oncology, Novartis Institutes for Biomedical Research, Basel, Switzerland.ORCID 0000-0002-6010-9169
Novartis (Switzerland) · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The TEAD (Sd in drosophila) transcription factors are essential for the Hippo pathway. Human VGLL4 and drosophila Tgi bind to TEAD/Sd via two distinct binding sites. These two regions are separated by few amino acids in VGLL4 but they are very distant from each other in Tgi. This difference prompted us to study whether it influences the interaction with TEAD4/Sd. We show that the full-length VGLL4/Tgi proteins behave as intrinsically disordered proteins. They have a similar affinity for TEAD4/Sd revealing that the length of the region between the two binding sites has little effect on the interaction. One of their two binding sites (high-affinity site) binds to TEAD4/Sd 100 times more tightly than to the other site, and size exclusion chromatography experiments reveal that VGLL4/Tgi only form trimeric complexes with TEAD4/Sd at high protein concentrations. In solution, therefore, VGLL4/Tgi may predominantly interact with TEAD4/Sd via their high-affinity site to create dimeric complexes. In contrast, when TEAD4/Sd molecules are immobilized on sensor chips used in Surface Plasmon Resonance experiments, one VGLL4/Tgi molecule can bind simultaneously with an enhanced affinity to two immobilized molecules. This effect, due to a local increase in protein concentration triggered by the proximity of the immobilized TEAD4/Sd molecules, suggests that in vivo VGLL4/Tgi could bind with an enhanced affinity to two nearby TEAD/Sd molecules bound to DNA. The presence of two binding sites in VGLL4/Tgi might only be required for the function of these proteins when they interact with TEAD/Sd bound to DNA.

Indexed as

Amino Acid SequenceAnimalsBinding SitesCarrier ProteinsCloning, MolecularDNADrosophila melanogasterDrosophila ProteinsEscherichia coliGene ExpressionGenetic VectorsHippo Signaling PathwayHumansImmobilized ProteinsIntrinsically Disordered ProteinsModels, MolecularCarrier ProteinsDNADrosophila ProteinsImmobilized ProteinsIntrinsically Disordered ProteinsRecombinant Proteinssd protein, DrosophilaTEAD4 protein, humanTEA Domain Transcription FactorsTgi protein, DrosophilaTranscription FactorsVGLL4 protein, humanhippo pathwayscallopedTEADTgitranscription factorVGLL4

Identifiers

PMID34075638
PMCPMC8376407
OpenAlexW3165853931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.